• Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts

    المصدر: Buzz FX / 04 مارس 2025 06:11:15   America/Chicago


    Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Shares of Vir Biotechnology, Inc. ( NASDAQ:VIR - Get Free Report ) have ea
    Read more...
شارك على،